Advice
prilocaine hydrochloride 2% hyperbaric solution for injection (Prilotekal®) is accepted for restricted use within NHS Scotland.
Indication under review: spinal anaesthesia SMC restriction: for use in spinal anaesthesia in ambulatory surgery settings such as day surgery units.
Prilocaine 2% hyperbaric solution for injection was associated with faster discharge times than a hyperbaric formulation of another local anaesthetic in one small single-centre, double-blind, randomised study. Use of this preparation may allow service improvement through benefits to individual patients or service delivery.
Download detailed advice239KB (PDF)
Medicine details
- Medicine name:
- prilocaine hydrochloride hyperbaric solution (Prilotekal)
- SMC ID:
- 665/10
- Indication:
- For spinal anaesthesia
- Pharmaceutical company
- Goldshield Pharmaceuticals Limited
- BNF chapter
- Anaesthesia
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 17 January 2011